STOUGHTON, Mass., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (COLL) today announced its intention to offer, subject to market and other conditions, $175,000,000 aggregate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback